Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new clinical research and response network for epidemic infections has been launched in sub-Saharan Africa with the support of a €10 million grant from the European and Developing Countries Clinical Trials Partnership (EDCTP).

The African coaLition for Epidemic Research, Response and Training (ALERRT) aims to reduce the health and socioeconomic impact of disease outbreaks in sub-Saharan Africa. Co-ordinated by Oxford, it will build a sustainable clinical and laboratory research preparedness and response network, with the operational readiness to rapidly implement clinical and laboratory research in support of outbreak control efforts.

ALERRT combines the strengths of 21 leading African and European partner organisations from nine African and four European countries. The partners have established a network of centres and clinics stretching across sub-Saharan Africa that will conduct research on epidemic-prone infectious disease and which will respond quickly to outbreaks.

Find out more (University of Oxford website)

Similar stories

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.